These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19031117)

  • 1. Cyclooxygenase-2 (COX-2) in carcinogenesis and selective COX-2 inhibitors for chemoprevention in gastrointestinal cancers.
    Fujimura T; Ohta T; Oyama K; Miyashita T; Miwa K
    J Gastrointest Cancer; 2007; 38(2-4):78-82. PubMed ID: 19031117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience.
    Fujimura T; Ohta T; Oyama K; Miyashita T; Miwa K
    World J Gastroenterol; 2006 Mar; 12(9):1336-45. PubMed ID: 16552798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of colorectal cancer - a new target needed?
    Spychalski M; Dziki L; Dziki A
    Colorectal Dis; 2007 Jun; 9(5):397-401. PubMed ID: 17504335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials.
    Garcia Rodriguez LA; Cea-Soriano L; Tacconelli S; Patrignani P
    Recent Results Cancer Res; 2013; 191():67-93. PubMed ID: 22893200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of cancers in gastrointestinal tract with cyclooxygenase 2 inhibitors.
    Wang R; Guo L; Wang P; Yang W; Lu Y; Huang Z; Tang C
    Curr Pharm Des; 2013; 19(1):115-25. PubMed ID: 22950494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of colorectal cancer: two steps forward, one step back?
    Half EE; Arber N
    Future Oncol; 2006 Dec; 2(6):697-704. PubMed ID: 17155896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for colon cancer and evaluation of chemoprevention with coxibs.
    Rex DK
    J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S41-50. PubMed ID: 11992750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention with special reference to inherited colorectal cancer.
    Lynch PM
    Fam Cancer; 2008; 7(1):59-64. PubMed ID: 17680350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAIDs and chemoprevention.
    Rao CV; Reddy BS
    Curr Cancer Drug Targets; 2004 Feb; 4(1):29-42. PubMed ID: 14965265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention.
    Fischer SM; Hawk ET; Lubet RA
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1728-35. PubMed ID: 21778329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.
    Gunter BR; Butler KA; Wallace RL; Smith SM; Harirforoosh S
    J Clin Pharm Ther; 2017 Feb; 42(1):27-38. PubMed ID: 28019014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?
    Manzano A; Pérez-Segura P
    ScientificWorldJournal; 2012; 2012():327341. PubMed ID: 22649288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: counterpoint.
    Jankowski J; Hunt R
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):1858-61. PubMed ID: 18708372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.
    Rostom A; Dubé C; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D;
    Ann Intern Med; 2007 Mar; 146(5):376-89. PubMed ID: 17339623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications.
    Chu AJ; Chou TH; Chen BD
    Front Biosci; 2004 Sep; 9():2697-713. PubMed ID: 15353307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.